An albumin-binding Gd-HPDO3A contrast agent for improved intravascular retention

Abstract

A new Gd-HPDO3A derivative with improved MR contrast enhancing efficiency, demonstrated in a murine tumor model and in mouse models for stable and vulnerable atherosclerotic plaques, due to increased intravascular retention.